Experienced in IgG4-Related Disease

Dr. Maurizio R. Zangari

Hematology Oncology | Hematology | Oncology
UAMS Health
University Of Arkansas For Medical Sciences
4301 W Markam St, 
Little Rock, AR 
Accepting New Patients
Offers Telehealth

Experienced in IgG4-Related Disease
UAMS Health
University Of Arkansas For Medical Sciences
4301 W Markam St, 
Little Rock, AR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Maurizio Zangari is a Hematologist Oncology specialist and a Hematologist in Little Rock, Arkansas. Dr. Zangari is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Zangari is currently accepting new patients.

His clinical research consists of co-authoring 131 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in AR
Hospital Affiliations
St Francis Medical Center
Uams Medical Center
Languages Spoken
English
Italian
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Arkansas Health and Wellness
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
HMO Partners
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Primewell Health Services
  • HMO
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • POS
QualChoice
  • MEDICARE MAPD
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES
4301 W Markam St, Little Rock, AR 72205
Call: 501-686-8000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

UARK 2008-03 Phase II Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy (No Prior Transplant)
UARK 2008-03 Phase II Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy (No Prior Transplant)
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2025
Intervention Type: Drug
Study Drugs: Melphalan, Velcade, Thalidomide, Dexamethasone, Cisplatin, Adriamycin, Cyclophosphamide, Etoposide
Study Phase: Phase 2
UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma Ages 65 and Under: A Trial Enrolling Subjects to Standard Total Therapy 3 (S-TT3)
UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma Ages 65 and Under: A Trial Enrolling Subjects to Standard Total Therapy 3 (S-TT3)
Enrollment Status: Active_not_recruiting
Publish Date: June 29, 2025
Intervention Type: Drug
Study Drugs: M-VTD-PACE, TT3-LITE Regimen (L-TT3)
Study Phase: Phase 3
A Phase II Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission (AS-CR) by Applying Non-Host-Exhausting and Timely Dose-Reduced Mel-80-CFZ-TD-Pace Transplant(s) With Interspersed Mel-20-CFZ-TD-Pace With CFZ-RD and CFZ-D Maintenance
A Phase II Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission (AS-CR) by Applying Non-Host-Exhausting and Timely Dose-Reduced Mel-80-CFZ-TD-Pace Transplant(s) With Interspersed Mel-20-CFZ-TD-Pace With CFZ-RD and CFZ-D Maintenance
Enrollment Status: Terminated
Publish Date: June 22, 2021
Intervention Type: Drug, Device
Study Drug: MEL-CFZ-TD-PACE
Study Phase: Phase 2
A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus, Genetically Engineered to Express NIS, With Cyclophosphamide, in Patients With Recurrent of Refractory Multiple Myeloma
A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus, Genetically Engineered to Express NIS, With Cyclophosphamide, in Patients With Recurrent of Refractory Multiple Myeloma
Enrollment Status: Completed
Publish Date: October 19, 2020
Intervention Type: Drug
Study Phase: Phase 2
Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes
Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes
Enrollment Status: Completed
Publish Date: October 15, 2019
UARK 2010-35, A Phase II Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma
UARK 2010-35, A Phase II Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma
Enrollment Status: Completed
Publish Date: May 19, 2017
Intervention Type: Drug
Study Phase: Phase 2
A Phase II Trial of a Novel Proteasome/IMiD Combination, Ixazomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma Patients
A Phase II Trial of a Novel Proteasome/IMiD Combination, Ixazomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma Patients
Enrollment Status: Withdrawn
Publish Date: January 23, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

131 Total Publications

Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma.
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma.
Journal: Cancer biomarkers : section A of Disease markers
Published: June 09, 2025
View All 131 Publications
Similar Doctors
Experienced in IgG4-Related Disease
Dr. Frits Van Rhee
Hematology Oncology | Hematology
Experienced in IgG4-Related Disease
Dr. Frits Van Rhee
Hematology Oncology | Hematology

University Of Arkansas For Medical Sciences

4301 W Markam St, 
Little Rock, AR 
 (0.1 miles away)
Languages Spoken:
English, Dutch
See accepted insurances
Accepting New Patients
Offers Telehealth

Frits Van Rhee is a Hematologist Oncology specialist and a Hematologist in Little Rock, Arkansas. Dr. Van Rhee is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Van Rhee is currently accepting new patients.

Experienced in IgG4-Related Disease
Dr. Brad P. Baltz
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Brad P. Baltz
Hematology Oncology | Hematology | Oncology

American Oncology Partners PA

5620 W Markham St, 
Little Rock, AR 
 (1.7 miles away)
501-508-7163
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Brad Baltz is a Hematologist Oncology specialist and a Hematologist in Little Rock, Arkansas. Dr. Baltz is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Familial Colorectal Cancer, and Pleuropulmonary Blastoma. Dr. Baltz is currently accepting new patients.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zangari's expertise for a condition
ConditionClose
  • Elite
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
    Dr. Zangari is
    Elite
    . Learn about Monoclonal Gammopathy of Undetermined Significance (MGUS).
    See more Monoclonal Gammopathy of Undetermined Significance (MGUS) experts
  • Multiple Myeloma
    Dr. Zangari is
    Elite
    . Learn about Multiple Myeloma.
    See more Multiple Myeloma experts
  • Relapsed Refractory Multiple Myeloma (RRMM)
    Dr. Zangari is
    Elite
    . Learn about Relapsed Refractory Multiple Myeloma (RRMM).
    See more Relapsed Refractory Multiple Myeloma (RRMM) experts
  • Smoldering Multiple Myeloma
    Dr. Zangari is
    Elite
    . Learn about Smoldering Multiple Myeloma.
    See more Smoldering Multiple Myeloma experts
  • Distinguished
  • Cardiac Amyloidosis
    Dr. Zangari is
    Distinguished
    . Learn about Cardiac Amyloidosis.
    See more Cardiac Amyloidosis experts
  • Cerebral Amyloid Angiopathy
    Dr. Zangari is
    Distinguished
    . Learn about Cerebral Amyloid Angiopathy.
    See more Cerebral Amyloid Angiopathy experts
  • Plasmacytoma
    Dr. Zangari is
    Distinguished
    . Learn about Plasmacytoma.
    See more Plasmacytoma experts
  • Primary Localized Cutaneous Amyloidosis
    Dr. Zangari is
    Distinguished
    . Learn about Primary Localized Cutaneous Amyloidosis.
    See more Primary Localized Cutaneous Amyloidosis experts
  • Waldenstrom Macroglobulinemia
    Dr. Zangari is
    Distinguished
    . Learn about Waldenstrom Macroglobulinemia.
    See more Waldenstrom Macroglobulinemia experts
  • Advanced
  • Bone Marrow Transplant
    Dr. Zangari is
    Advanced
    . Learn about Bone Marrow Transplant.
    See more Bone Marrow Transplant experts
  • Hereditary Cerebral Amyloid Angiopathy
    Dr. Zangari is
    Advanced
    . Learn about Hereditary Cerebral Amyloid Angiopathy.
    See more Hereditary Cerebral Amyloid Angiopathy experts
  • Light Chain Deposition Disease (LCDD)
    Dr. Zangari is
    Advanced
    . Learn about Light Chain Deposition Disease (LCDD).
    See more Light Chain Deposition Disease (LCDD) experts
  • Primary Amyloidosis
    Dr. Zangari is
    Advanced
    . Learn about Primary Amyloidosis.
    See more Primary Amyloidosis experts
  • Primary Immunodeficiency (PID)
    Dr. Zangari is
    Advanced
    . Learn about Primary Immunodeficiency (PID).
    See more Primary Immunodeficiency (PID) experts
  • Schnitzler Syndrome
    Dr. Zangari is
    Advanced
    . Learn about Schnitzler Syndrome.
    See more Schnitzler Syndrome experts
View All 7 Advanced Conditions
  • Experienced
  • Agranulocytosis
    Dr. Zangari is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • B-Cell Lymphoma
    Dr. Zangari is
    Experienced
    . Learn about B-Cell Lymphoma.
    See more B-Cell Lymphoma experts
  • Bone Marrow Aspiration
    Dr. Zangari is
    Experienced
    . Learn about Bone Marrow Aspiration.
    See more Bone Marrow Aspiration experts
  • Castleman Disease
    Dr. Zangari is
    Experienced
    . Learn about Castleman Disease.
    See more Castleman Disease experts
  • Chronic B-Cell Leukemia (CBCL)
    Dr. Zangari is
    Experienced
    . Learn about Chronic B-Cell Leukemia (CBCL).
    See more Chronic B-Cell Leukemia (CBCL) experts
  • Chronic Familial Neutropenia
    Dr. Zangari is
    Experienced
    . Learn about Chronic Familial Neutropenia.
    See more Chronic Familial Neutropenia experts
View All 34 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved